Login
Home
About Us
Contact Us
Site Map
Search for
Home
>
Knowledge Centre
>
Online Learning & Teaching
>
ESC Slide Resource
>
Heart Failure 2005
Online Learning & Teaching
Webcasts
ESC Slide Resource
World Congress of Cardiology - ESC Congress 2006
ESC Congress 2005 Stockholm
ESC Congress 2004 Munich
ESC Congress 2003 Vienna
Management of CVD Risk in the Perimenopausal Woman 2006
EACPR Leuven Spring Meeting 2005
Heart Failure 2005
ESC Policy Conference on CVD in Women
Education in Heart
Educational Programme Resources
Scientific and Knowledge Search
Clinical Case Portal
Echocardiography
Heart Failure Scientific Reports
CME Calendar
Pharmacological treatment: is there any evidence-based medicine for the very old?
Presentation title:
Pharmacological treatment: is there any evidence-based medicine for the very old?
Author(s):
Metra M.
Date:
14 June 2005
[Download complete file]
Click a thumbnail below to view an individual slide:
Pharmacological Treatment: is There Any Evidence-based Medicine for the Very Old? Marco Metra Cattedra di Cardiologia Università di Brescia
Mean Age of the Patients with Heart Failure in Epidemiological Studies
Mean Age and Proportions of Elderly Patients in Multicenter Trials
Factors Distinguishing HF in the Elderly from HF at Middle Age
Factors Distinguishing HF in the Elderly from HF at Middle Age
Baseline Characteristics of Patients Recruited in COMET Subdivided According to Age (mean, 62 ys.; range, 18-90)
Clinical Characteristics of the Patients with HF According to Age: IMPROVEMENT Study 8256 patients in 15 countries, 1999-2000
Concomitant Diseases of the Patients with HF According to Age: IMPROVEMENT Study 8256 patients in 15 countries, 1999-2000
Most Common Non-cardiac Diseases for Patients > 65 years with CHF: An analysis of 122 630 subjects
Non-cardiac Comorbidity Increases Preventable Hospitalizations among Medicare Beneficiaries with CHF A survey of 122 630 Subjects Aged > 65 years
Incidence of Precipitating Factors as Causes of Hospital Admissions in Patients with Heart Failure
Management of HF in the Elderly: General Measures
Effect of Antihypertensive Therapy in the Primary Prevention of HF in Older Adults
Pharmacological therapy of heart failure due to Left Ventricular Systolic Dysfunction
Treatment of HF in the Elderly: What Do the Guidelines Say
Treatment of HF in the Elderly: What Do the Guidelines Say
Treatment of HF in the Elderly: What Do the Guidelines Say
Elderly Age is an Independent Predictor of Lack of Prescription of ACE Inhibitors: Results from the EuroHeart Failure Survey
ACEi/ARBs Prescriptions in the Patients with HF According to Age: IMPROVEMENT Study 8256 patients in 15 countries, 1999-2000
Effects of ACE inhibitors on outcome in patients subdivided on the basis of their age: Meta-analysis of the SOLVD, SAVE, AIRE and TRACE trials
Treatment of HF in the Elderly: What Do the Guidelines Say
Elderly Age is an Independent Predictor of Lack of Prescription of Beta-blockers: Results from the EuroHeart Failure Survey
Beta-blockers Prescriptions in the Patients with HF According to Age: IMPROVEMENT Study 8256 patients in 15 countries, 1999-2000
BRING UP Reasons for Not Commencing β-Blockade
BRING UP Independent Predictors of Blocker Tolerability
Effect of Bisoprolol on Mortality in Different Age Subgroups
Efficacy of Metoprolol CR/XL in Elderly Patients with Heart Failure: the MERIT-HF Study
Beta-blockers Reduce Mortality also in Elderly Patients: Meta-analysis of >12,000 Patients in Large-scale Trials (BEST, Carvedilol US, CIBIS-II, COPERNICUS, MERIT-HF)
SENIORS Trial: All Cause Mortality or CV Hospital Admission (Primary Outcome)
Death or CV Hospitalisation by Subgroup
Treatment of HF in the Elderly: What Do the Guidelines Say
Elderly Age is an Independent Predictor of Lack of Prescription of Spironolactone: Results from the EuroHeart Failure Survey
Spironolactone-induced hyperkaliemia and renal insufficiency in patients with heart failure
Treatment of HF in the Elderly: What Do the Guidelines Say
Effects of Losartan Compared with Captopril on Mortality in Patients with Symptomatic Heart Failure: ELITE II Results
Lack of Influence of Age on the Effects of Valsartan in Val-HeFT Trial
Treatment of HF in the Elderly: What Do the Guidelines Say
Lack of effect of age on the effects on digoxin on outcome: Results from the DIG study
Oral Anticoagulant Prescriptions in the Patients with HF According to Age: IMPROVEMENT Study 8256 patients in 15 countries, 1999-2000
Randomised Controlled Trial of Cardiac Rehabilitation in Elderly Patients with HF
Effects of a Multidisciplinary Intervention to Prevent the Readmission of Patients with Heart Failure (Washington University HF disease management trial)
Randomized Controlled Trial of Specialist Nurse Intervention in Heart Failure
Effects of Disease Management Programs on Hospitalization Rates in Heart Failure
Efficacy of Disease Management Programmes in Reducing Hospital readmissions in Older (>70 ys) Patients with HF
Is your ER department equipped and aware of the ESC guidelines supporting early use of dual antiplatelet therapy in ACS patients?
Absolutely
Yes, in most cases
Not sure
Site Map
|
Contact Us
|
Terms & Conditions
|
Privacy
Copyright © European Society of Cardiology 1997 - 2005 - All rights reserved